MANILA, Philippines — Local pharmaceutical company Unilab reminded the public Thursday to use paracetamol properly and within the recommended dose to ensure safety and efficacy.
Unilab issued the reminder amid the reported demand surge for paracetamol which is used to relieve pain and reduce fever.
“With the sudden surge of sickness today, people turn to paracetamol—a commonly used over-the-counter medication for fever, headache, and pain. But it’s important to remember its proper usage and dose to ensure safety and efficacy,” Unilab said in an advisory.
According to Unilab, the usual recommended dose for adults is one to two 500 milligram tablets every four to six hours.
The pharmaceutical firm said users should not exceed a maximum of eight tablets or 4,000 milligrams of paracetamol per day.
Unilab also advised the public not to use paracetamol with other products also containing paracetamols such as cough and cold preparations, fever ruducers, and pain relievers.
Other reminders include the following:
The Department of Trade and Industry and the Department of Health assured the public that there is no shortage of paracetamol and other drugs for flu-like symptoms amid the reported consumer rush.
A new study by the Ateneo Policy Center and Unilab Center for Health Policy highlights inefficiencies in how local government units (LGUs) spend their health budgets, prompting the Department of Budget and Management (DBM) to call for fiscal reforms.
The biggest names in the music industry, Gary Valenciano, BINI, Darren, Maki, and Mayonnaise, will come together at the Araneta Coliseum to celebrate healthcare
Over 80 economic and business journalists joined the EJAP-Unilab Health and Wellness Day on June 21, 2025, at the Bayanihan Center—EJAP’s first wellness event since 2021.
Local pharmaceutical giant United Laboratories Inc. (Unilab) is looking to convert its Laguna campus into a designated pharmaceutical economic zone, a move seen boosting the local drug manufacturing industry.
The initiative is the long-unrealized mandate under Section 11 of the Universal Health Care (UHC) Law